Elizabeth Damstetter, MD
Dermatology · Glenview, ILNPI 1184935611
Payments from drug & device makers
Across 137 payments — averaging $223.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$29K
- AbbVie$714
- Pfizer$424
- Lilly USA, LLC$188
- Sun Pharmaceutical Industries Inc.$150
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$141
- plus $266 from 7 others
What the payments were for
- Speaking & faculty fees$26,27686%
- Travel & lodging$8163%
- Food & beverage$3,51711%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 68 | $28,740 |
| AbbVie(2 entities) | 21 | $714 |
| Pfizer | 10 | $424 |
| Lilly USA, LLC | 16 | $188 |
| Sun Pharmaceutical Industries Inc. | 3 | $150 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $141 |
| Dermavant Sciences, Inc. | 4 | $94 |
| Sanofi | 2 | $46 |
| Organon | 7 | $43 |
| Almirall LLC | 2 | $27 |
| EPI Health, LLC | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$30,624 in reported general payments places this provider in the 85th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $48,646 |
| Clobetasol Propionate | 13 | $763 |
| Dutasteride | 23 | $739 |
| Desonide | 14 | $464 |
| Triamcinolone Acetonide | 26 | $339 |
| Ketoconazole | 20 | $314 |
| Minoxidil | 57 | $299 |
| Finasteride | 14 | $210 |
| Doxycycline Hyclate | 11 | $117 |
| Mupirocin | 25 | $111 |
| Gentamicin Sulfate | 12 | $103 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Glenview
- Lady DyGlenview$126K
- Jessica BorowiczGlenview$91K
- Michael BukhaloRolling Meadows$6.8M
- Stephanie MehlisSkokie$6.4M
- Ahmad AminNaperville$4.6M
- George LewittNorthbrook$4M
- Raj ChovatiyaChicago$3.7M
- Peter LioChicago$2.5M
- Paul GetzWest Dundee$2.4M
- Kyle AmberBerwyn$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.